ABSTRACT
INTRODUCTION
In the last few years, Cancer has become an important leading precursor towards mortality rate (8.2 millions, 2012 ) & estimated to increase via almost 70% over the next two decades. 1 The exact cause is mysterious but mutation in the cell proteins which encodes specific gene plays a crucial role towards its pathogenesis. [2] [3] The serious problem arises due to action of anticancer 2 drugs on the proliferating cells of body like alimentary tract, bone marrow cells, and epidermal cells which lead to adverse effects such as hair loss, anemia & other infectious diseases. 4 Although, the various synthetic drugs have shown promising potential against this disease but poor selectivity issue remains a major concern. To date, there is no safe and effective cancer therapy available, thus, there is an urgent need to explore the anticancer properties of the existing molecules on which safety data is already available. 13 These results indicate that pyrethroid insecticide at lower concentration have potential to act as anticancer agent.
Docking is now commonly used in virtual screening or lead optimization for drug screening and design. It is used to predict the preferred orientation of ligand (Protein-ligand docking) or protein (protein-protein docking) towards a relevant target to form a stable complex. 14 In most cases, one can choose the best 'binding affinity' to be the potent ligand for further development. 15 Therefore in the present investigation, we have tried to assess the in-silico interactions of pyrethroid derivatives against different cancer proteins (estrogen, androgen & cervix).
MATERIALS & METHODS
Maestro 9.2 version software (Schrodinger LLC suite) was used for docking simulation.
Molecular docking software was installed in single machine running on core TM processor with 2 GB RAM and 180 GB with centrp linux as the operating system. The pyrethroid chemical entities (type 1 & type 2) data were collected from the literature.
Protein preparation
The crystal structures of cancer receptors (PDB: 3ERT- of hydrogen bond and restorative energy minimization steps were applied to correct the geometry of receptors.
Ligand library
The structure of all the tested compounds were drawn in chem draw ultra 8.0 (Cambridge soft), saved in three dimensional structures (.mol file) and finally imported into maestro project table.
Ligands preparations plus energy minimization were completed by using least square OPLS_2005 force field. The conformers (max 32/ligand) were generated and filtered to their energy minima with possible state generation (pH 7±2.0).
Grid generation & docking calculation
The electrostatic and vander wall's potential of binding pocket was assigned through grid box with maximum 14E edge length around the active site of internal ligand. Extra precision (XP)
glide docking was applied. The docking pose analysis was done through XP visualizer. The insilico docking results have analyzed not only glide score basis but in addition different possible interactions of the pyrethroids with the different residues of cancer receptors were too seen.
RESULT & DISCUSSION
The reference ligands along with type 1 & type 2 pyrethroids were docked against cancer proteins (PDB: 3ERT, 2PIT & 3F81). The ranking were evaluated by top HITs glide score of the test ligands. Table 1 
Resmethrin
The hydrophobic interactions (Pro26, Leu25, Leu16, Pro162, Tyr23 & Cys22) and π-π interaction (Tyr128) were examined.
Fenpropathrin
This ranked compound was simply capable of hydrophobic interactions (Tyr128, Leu25, Pro26, Met69, Tyr23, Leu16, Leu167 & Pro167) with cervix cancer protein.
CONCLUSIONS
The glide score of tested pyrethroids were obtained from -1.12 to -7.47 which indicate the strong affinity towards cancer cell receptors. Top screened pyrethroids like resmethrin (3ERT & 2PIT)
& fluvalinate (3F81) have resulted in most hopeful hits to anticancer assessment. The widespread applications of pyrethroids among population have turned researchers focus to unlock its novel potential and thus this recent preliminary molecular docking study can serve as an important breakthrough to further understand its anticancer nature with its clear mechanism. However, the complete efficacy and safety studies should be assessed to start a clinical trial for these compounds.
